The Study of Suppressive Effects of Pasteurella multocida B:2 on Calf Lymphocytes

Document Type : Full Research Paper

Authors

1 Asisstant Prefossor, Department of Poultry Bacterial Diseases, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organisation (AREEO), Tehran, Iran

2 Asisstant Prefossor, Department of Poultry Bacterial Diseases, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organisation (AREEO), Tehran Iran

3 Student BSc, Scientific Biology Faculty, Kharzmi University, Karaj, Iran.

Abstract

Haemorrhagic Septicaemia (HS) is an acute disease of cattle and buffaloes in tropical countries, caused by Pasteurella multocida (P. multocida) serotype B:2 , a Gram-negative coccobacillus. Some evidences of immunosuppression have been observed after a challenge with a virulent strain on vaccinated calves. To further investigate the observed suppressive effect, the present study was set up using a cell-free extract and calf PBMCs, for in vitro experiments. A lymphocyte stimulation assay was used to assess the effects of a cell-free extract (CFE) of P. multocida on peripheral blood mononuclear cells (PBMCs), isolated from calves. To assess the proliferative response of PBMCs obtained from calf, ConA was added to the PBMCs culture, and the proliferation was quantified by assessment of radioactivity of absorbed 3H-Thymidine. In order to characterize the agent(s), the CFE extract suppressive activity was assessed after heating and dialyzing and also by using an outer-membrane protein (OMP) preparation in experiments. Results indicated that addition of CFE at 50 μg/ml caused a five fold decrease in the proliferative response to ConA. Heating at 80˚C for five min completely destroyed the suppressive properties. An outer membrane protein (OMP) preparation of P. multocida B:2 markedly suppressed the proliferative response of PBMCs to ConA. The study was indicative of a suppressive component(s) of P. multocida B:2 on proliferative response of calf PBMCs to ConA. The active part of the suppressive agent(s) was likely to be at least in some part of protein, and is of OMPs.

Keywords

Main Subjects


1. Brunham, R. C., Plummer, F. A. & Stephens, R. S. 1993. Bacterial antigenic variation, host immune response, and pathogen-host co-evolution. Infectious Immunity. 61: 2273-2276.
2. Hornef, M. W., Wick, M. J., Rhen, M. & Normark, S. 2002. Bacterial strategies for overcoming host innate and adaptive immune responses. Nature Immunology. 3: 1033-1040.
3. Tizard, I.R., 2013. Veterinary Immunology, in: Immunity to Bacteria and Fungi, 9th ed. USA, Philadelphia, Saunders-Elsevier, pp. 283-295.
4. Schwab, J. H. 1975. Suppression of the immune response by microorganisms. Bacteriological Reviews. 39: 121-143.
5. Aktories, K., Orth, J. H.C., Adler, B. 2012. Pasteurella multocida, Molecular biology, Toxins and Infection, 1ed. Germany, Berlin Heidelberg, Springer-Verlang.pp. pp. 63-72.
6. Jacques, M. 2002. Virulence factors of Pasteurellaceae, formidable animal pathogens. ASM News. 68: 175-179.
7. Benkirane, A., DE Alwis, M.C.L. 2002. Haemorrhagic septicaemia, its significance, prevention and control in Asia. Veterinary Medicine – Czech. 47: 234-240.
8. Kubatzky, K. F., Kloos, B., and Hildebrand, D. 2013. Signaling cascades of Pasteurella multocida toxin in immune evasion. Toxins (Basel). 5: 1664–1681.
9. Srivastava, S. K. 1998. Outer membrane protein of Pasteurella multocida serotype B:2 is immunogenic and antiphagocytic. Indian Journal of Experimental Biology. 36: 530-532.
10. Ataei, S., Burchmore, R., Hodgson, J., Finucane, A., Parton, R., Coote, JG. 2009. Identification of immunogenic proteins associated with protection against haemorrhagic septicaemia after vaccination of calves with a live-attenuated aroA derivative of Pasteurella multocida B:2.Research in Veterinary Science. 87(2):207-10.
11. Davies, R. L., Parton, R., Coote, J. G., Gibbs, H. A., Freer, J. H. 1992. Outer-membrane protein and lipopolysaccharide variation in Pasteurella haemolytica serotype A1 under different growth conditions. Journal of General Microbiology. 138: 909-922.
12. OIE, 2012. Haemorrhagic septicaemia. In Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, 2.4.12, 7th edition, 2012: OIE.
13. Vanden Bush, T. J., Rosenbusch, R. F. 2002. Mycoplasma bovis induces apoptosis of bovine lymphocytes. FEMS Immunology & Medical Microbiology. 32: 97-103.
14. Vanden Bush, T. J. & Rosenbusch, R. F. (2004). Characterization of a lympho-inhibitory peptide produced by Mycoplasma bovis. Biochemistry and Biophysics Research Communications 315, 336-341.
15. De Alwis, M.C.L. (1999). Haemorrhagic Septicaemia. In Australian Centre for International Agricultural Research (ACIAR) Monograph No 57, pp. 141. Canberra Australia.
16. Jordan, R. W., Hamilton, T. D., Hayes, C. M., Patel, D., Jones, P. H., Roe, J. M. & Williams, N. A. 2003. Modulation of the humoral immune response of swine and mice mediated by toxigenic Pasteurella multocida. FEMS Immunology & Medical Microbiology. 39: 51-59.
17. Hildebrand, D., Sahr, A., Wolfle, S. J., Heeg, K., and Kubatzky, K. F. 2012. Regulation of Toll-like receptor 4-mediated immune responses through Pasteurella multocida toxin-induced G protein signalling. Cell Communication and Signaling. 10: 22.
18. Hildebrand, D., Heeg, K., and Kubatzky, K. F. 2015. Pasteurella multocida Toxin Manipulates T Cell Differentiation. Frontiers in Microbiology. 6: 1273.
19. Stevens, M. G., Olsen, S. C., Cheville, N. F. 1997. Comparative effects of bovine cytokines on cattle and bison peripheral blood mononuclear cell proliferation. Comparative Immunology, Microbiology and Infectious Diseases. 20: 155-162.
20. Ryu, H. I., Kim, C. J. 2000. Immunologic reactivity of a lipopolysaccharide-protein complex of type A Pasteurella multocida in mice. Journal of Veterinary Science. 1: 87-95.
21. Yao, T., Mecsas, J., Healy, J. I., Falkow, S. & Chien, Y. 1999. Suppression of T and B lymphocyte activation by a Yersinia pseudotuberculosis virulence factor, yopH. The Journal of Experimental Medicine. 190: 1343-1350.
22. Sing, A., Roggenkamp, A., Geiger, A. M. & Heesemann, J. 2002. Yersinia enterocolitica evasion of the host innate immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice. Journal of Immunology. 168: 1315-1321.
23. Gerke, C., Falkow, S., Chien, Y. H. 2005. The adaptor molecules LAT and SLP-76 are specifically targeted by Yersinia to inhibit T cell activation. The Journal of Experimental Medicine. 201: 361-371.